Evelyne Roets1, Karina Tukanova1, Anouk Govarts1, Pol Specenier2,3. 1. Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. 2. Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Pol.Specenier@uza.be. 3. Department of Oncology, University Hospital of Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium. Pol.Specenier@uza.be.
Abstract
PURPOSE: To summarize the literature on quality of life (QoL) in patients with oropharyngeal squamous cell carcinoma (OPSCC). METHODS: The PubMed database was searched using the inclusion criteria "oropharyngeal cancer," "quality of life," "human," and "English," the exclusion criterion "recurrent," and publication date between January 1, 2005 and October 26, 2015. RESULTS: The search yielded 98 articles of which 17 fulfilled all selection criteria. Intensity-modulated radiotherapy (IMRT) showed a better outcome for several QoL domains and was superior to chemoradiotherapy (CRT) in some studies. At 12-month follow up, deterioration of QoL was seen in a smaller proportion of patients after surgery and postoperative radiotherapy (S&PORT) in comparison to CRT. For all treatment modalities, the most important worsening for several QoL domains was seen at 3 months. Stage III/IV patients experienced a greater deterioration of QoL scores for most scores. No consistent results were reported for the correlation between xerostomia assessed with QoL questionnaires and objective swallowing function assessed with modified barium swallow videofluoroscopy. CONCLUSION: The different tools used for the assessment of patient-reported QoL and objective measurement of functional outcome make it difficult to evaluate the effect of different treatment modalities. In general, we can conclude that a non-surgical approach is associated with worse QoL scores. IMRT minimizes radiation to the surrounding tissue and therefore has a better outcome in several QoL domains in comparison to conventional RT.
PURPOSE: To summarize the literature on quality of life (QoL) in patients with oropharyngeal squamous cell carcinoma (OPSCC). METHODS: The PubMed database was searched using the inclusion criteria "oropharyngeal cancer," "quality of life," "human," and "English," the exclusion criterion "recurrent," and publication date between January 1, 2005 and October 26, 2015. RESULTS: The search yielded 98 articles of which 17 fulfilled all selection criteria. Intensity-modulated radiotherapy (IMRT) showed a better outcome for several QoL domains and was superior to chemoradiotherapy (CRT) in some studies. At 12-month follow up, deterioration of QoL was seen in a smaller proportion of patients after surgery and postoperative radiotherapy (S&PORT) in comparison to CRT. For all treatment modalities, the most important worsening for several QoL domains was seen at 3 months. Stage III/IV patients experienced a greater deterioration of QoL scores for most scores. No consistent results were reported for the correlation between xerostomia assessed with QoL questionnaires and objective swallowing function assessed with modified barium swallow videofluoroscopy. CONCLUSION: The different tools used for the assessment of patient-reported QoL and objective measurement of functional outcome make it difficult to evaluate the effect of different treatment modalities. In general, we can conclude that a non-surgical approach is associated with worse QoL scores. IMRT minimizes radiation to the surrounding tissue and therefore has a better outcome in several QoL domains in comparison to conventional RT.
Entities:
Keywords:
Concurrent chemoradiation therapy (CRT); Dysphagia; Intensity-modulated radiotherapy (IMRT); Oropharyngeal cancer; Quality of life; Surgery and postoperative radiotherapy
Authors: Peter C Levendag; David N Teguh; Peter Voet; Henri van der Est; Inge Noever; Wilhelmus J M de Kruijf; Inger-Karine Kolkman-Deurloo; Jean-Briac Prevost; Johan Poll; Paul I M Schmitz; Ben J Heijmen Journal: Radiother Oncol Date: 2007-08-21 Impact factor: 6.280
Authors: Jeffrey M Vainshtein; Kent A Griffith; Felix Y Feng; Karen A Vineberg; Douglas B Chepeha; Avraham Eisbruch Journal: Int J Radiat Oncol Biol Phys Date: 2014-05-03 Impact factor: 7.038
Authors: Martina A Broglie; Alex Soltermann; Sarah R Haile; Christof Röösli; Gerhard F Huber; Stephan Schmid; Sandro J Stoeckli Journal: Laryngoscope Date: 2012-11-14 Impact factor: 3.325
Authors: Abrahim Al-Mamgani; Peter van Rooij; Lisa Tans; Gerda M Verduijn; Aniel Sewnaik; Rob J Baatenburg de Jong Journal: Radiother Oncol Date: 2013-02-08 Impact factor: 6.280
Authors: Min Yao; Lucy H Karnell; Gerry F Funk; Heming Lu; Ken Dornfeld; John M Buatti Journal: Int J Radiat Oncol Biol Phys Date: 2007-08-08 Impact factor: 7.038
Authors: Peter T Dziegielewski; Theodoros N Teknos; Kasim Durmus; Matthew Old; Amit Agrawal; Kiran Kakarala; Anna Marcinow; Enver Ozer Journal: JAMA Otolaryngol Head Neck Surg Date: 2013-11 Impact factor: 6.223
Authors: M Čanković; M Tešić; M Jevtić; D Stevanović; M-B Jovanović; D Kostić; J Antić; S-K Trivić Journal: Med Oral Patol Oral Cir Bucal Date: 2022-07-01
Authors: Puja Aggarwal; Katherine A Hutcheson; Adam S Garden; Frank E Mott; Charles Lu; Ryan P Goepfert; Clifton D Fuller; Stephen Y Lai; G Brandon Gunn; Mark S Chambers; Erich M Sturgis; Ehab Y Hanna; Sanjay Shete Journal: Cancer Date: 2021-08-06 Impact factor: 6.860